Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma

BACKGROUND: Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conj...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ali, Meser M., Janic, Branislava, Babajani-Feremi, Abbas, Varma, Nadimpalli R. S., Iskander, A. S. M., Anagli, John, Arbab, Ali S.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2010
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806917/
https://ncbi.nlm.nih.gov/pubmed/20090952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0008727
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires